SMMT
SMMT
NASDAQ · Biotechnology

Summit Therapeutics Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks
$14.25
+0.00 (+0.00%)
As of Jun 24, 9:45 PM ET ·
Analyst Consensus
Buy
24
Analysts
High
Coverage
Buy 16 67%
Hold 6 25%
Sell 2 8%
Price Target
Analyst Price Target +1,276.0% upside
Low Target $141.53
Average Target $196.08
High Target $244.39
Current Price $14.25
Current
$14.25
Target
$196.08
$141.53 $196.08 avg $244.39
Scenario Analysis
Bear Case
$141.53
893.2%
Low target
Base Case
$196.08
+1,276.0%
Avg target
Bull Case
$244.39
+1,615.0%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$30.98
-54.0% from high
52-Week Low
$12.55
+13.5% from low
50-Day SMA
$16.75
-14.9% vs SMA
200-Day SMA
$20.83
-31.6% vs SMA
RSI (14)
54.0
Neutral
Target vs 52W High
$196.08
+532.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 78% $257.58 +9.7%
AMGN
Amgen Inc
 Hold 44 50% $190.87 -45.7%
GILD
Gilead Sciences Inc
 Strong Buy 39 82% $362.68 +189.8%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 40 83% $438.34 -7.8%
REGN
Regeneron Pharmaceuticals
 Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 37 76% $102.31 -65.2%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -32.8%
NTRA
Natera Inc
 Strong Buy 27 89% $142.91 -45.0%